NMRA
Neumora Therapeutics, Inc.
Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer
Total Trades
31
Buys
20
Sells
10
Largest Trade
$1M+
Insiders
11
Institutional Funds
74
Inst. Value
$1M+
Activist Filings
12
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Aurora Daljit Singh | See Remarks | SELL | $100K–$500K | 115K | $2.68 | Nov 13, 2025 |
| Burow Kristina | Director | BUY | $1M+ | 1.9M | $2.61 | Oct 29, 2025 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $1M+ | 1.9M | $2.61 | Oct 29, 2025 |
| ARCH Venture Partners X, LLC | 10% Owner | BUY | $1M+ | 1.9M | $2.61 | Oct 29, 2025 |
| BERNS PAUL L | See Remarks | SELL | $15K–$50K | 14K | $1.69 | Feb 20, 2025 |
| Milligan Michael Lee | See Remarks | SELL | $1K–$15K | 2K | $1.69 | Feb 20, 2025 |
| Aurora Daljit Singh | Chief Strategy Off… | SELL | $1K–$15K | 9K | $1.68 | Feb 20, 2025 |
| Lenz Robert A. | Head of R&D | SELL | $1K–$15K | 6K | $1.67 | Feb 20, 2025 |
| Pinto Joshua | President | SELL | $1K–$15K | 8K | $1.67 | Feb 20, 2025 |
| Fust Matthew K | Director | EXERCISE | $100K–$500K | 22K | $5.83 | Oct 18, 2024 |
| Fust Matthew K | Director | SELL | $100K–$500K | 22K | $17.03 | Oct 18, 2024 |
| Lenz Robert A. | Head of R&D | SELL | $100K–$500K | 14K | $15.06 | Oct 11, 2024 |
| Pinto Joshua | CFO | SELL | $100K–$500K | 16K | $11.39 | Aug 27, 2024 |
| Pinto Joshua | CFO | SELL | $500K+ | 84K | $11.67 | Aug 26, 2024 |
| Burow Kristina | Director | BUY | $100K–$500K | 35K | $11.77 | Nov 15, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $100K–$500K | 35K | $11.77 | Nov 15, 2023 |
| Burow Kristina | Director | BUY | $1M+ | 141K | $10.98 | Nov 14, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $1M+ | 141K | $10.98 | Nov 14, 2023 |
| Burow Kristina | Director | BUY | $1M+ | 96K | $11.49 | Nov 8, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $1M+ | 96K | $11.49 | Nov 7, 2023 |
| Burow Kristina | Director | BUY | $1M+ | 77K | $13.68 | Sep 29, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $1M+ | 77K | $13.68 | Sep 29, 2023 |
| Burow Kristina | Director | BUY | $500K+ | 59K | $11.97 | Sep 28, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $500K+ | 59K | $11.97 | Sep 28, 2023 |
| ARCH Venture Partners XII, LLC | 10% Owner | BUY | $1M+ | 101K | $11.19 | Sep 26, 2023 |
| Burow Kristina | Director | BUY | $1M+ | 101K | $11.19 | Sep 26, 2023 |
| Burow Kristina | Director | BUY | $1M+ | 1.5M | $17.00 | Sep 20, 2023 |
| ARCH Venture Partners X, LLC | 10% Owner | BUY | $1M+ | 1.5M | $17.00 | Sep 20, 2023 |
| ARCH Venture Partners X, LLC | 10% Owner | BUY | $1M+ | 1.5M | $17.00 | Sep 20, 2023 |
| Gosebruch Henry O | President & CEO | BUY | $100K–$500K | 15K | $12.62 | Sep 20, 2023 |
| AMGEN INC | 10% Owner | BUY | $1M+ | 1.8M | $17.00 | Sep 19, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 74 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Siren, L.L.C. | 6.3M | $1M+ | SH |
| Point72 Asset Management, L.P. | 3.7M | $1M+ | SH |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3.3M | $1M+ | SH |
| ICONIQ Capital, LLC | 2.6M | $1M+ | SH |
| Lunate Capital Ltd | 2.1M | $1M+ | SH |
| JOHNSON & JOHNSON | 1.8M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.4M | $1M+ | SH |
| Ikarian Capital, LLC | 1.3M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 967K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 825K | $1M+ | SH |
| JANE STREET GROUP, LLC | 777K | $1M+ | SH |
| AlphaCore Capital LLC | 639K | $1M+ | SH |
| VANGUARD GROUP INC | 535K | $500K+ | SH |
| GSA CAPITAL PARTNERS LLP | 534K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 512K | $500K+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 474K | $500K+ | SH |
| STATE STREET CORP | 389K | $500K+ | SH |
| FEDERATED HERMES, INC. | 314K | $500K+ | SH |
| Cerity Partners LLC | 257K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 239K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 19, 2026
4.9%
8.2M shares
K2 HealthVentures Equity Trust LLC
SC 13G/A · Feb 17, 2026
5.0%
9.0M shares
SC 13D/A · Oct 29, 2025
20.6%
33.8M shares
K2 HealthVentures Equity Trust LLC
SC 13G · Aug 11, 2025
6.6%
11.4M shares
SC 13G/A · May 12, 2025
2.2%
3.5M shares
SC 13G/A · Feb 13, 2025
5.1%
8.2M shares
SC 13G · Nov 12, 2024
4.7%
7.5M shares
SC 13G · Jul 8, 2024
5.4%
8.6M shares
SC 13G · Jul 8, 2024
5.4%
8.6M shares
SC 13G · Feb 14, 2024
5.2%
8.0M shares
SC 13G · Feb 13, 2024
5.0%
7.6M shares
SC 13D · Sep 27, 2023
23.2%
3.5B shares